These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2557664)

  • 1. Prevention of cytomegalovirus infection after marrow transplantation.
    Meyers JD
    Rev Infect Dis; 1989; 11 Suppl 7():S1691-705. PubMed ID: 2557664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of cytomegalovirus infection after marrow transplantation.
    Meyers JD
    Bone Marrow Transplant; 1988 Mar; 3(2):95-104. PubMed ID: 2844342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of cytomegalovirus infection.
    Bowden RA; Meyers JD
    Semin Hematol; 1990 Apr; 27(2 Suppl 1):17-21; discussion 28-9. PubMed ID: 2160127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of cytomegalovirus infection.
    Meyers JD
    Am J Med; 1988 Aug; 85(2A):102-6. PubMed ID: 2841853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
    Gluckman E; McMazeron ; Keable H; Meletis J; Bombail D; Jolivet I; Huart JJ; Nebout T; Cavazzana M; De Castro H
    Nouv Rev Fr Hematol (1978); 1987; 29(1):17-21. PubMed ID: 3035485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus prophylaxis and treatment following bone marrow transplantation.
    Tsinontides AC; Bechtel TP
    Ann Pharmacother; 1996 Nov; 30(11):1277-90. PubMed ID: 8913411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infections after allogeneic bone marrow transplantation.
    Winston DJ; Ho WG; Champlin RE
    Rev Infect Dis; 1990; 12 Suppl 7():S776-92. PubMed ID: 2173107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.
    Flechner SM; Avery RK; Fisher R; Mastroianni BA; Papajcik DA; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC
    Transplantation; 1998 Dec; 66(12):1682-8. PubMed ID: 9884259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection and renal transplantation.
    Metselaar HJ; Weimar W
    J Antimicrob Chemother; 1989 Jun; 23 Suppl E():37-47. PubMed ID: 2550411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the prevention of cytomegalovirus disease after marrow transplantation.
    Goodrich JM; Boeckh M; Bowden R
    Clin Infect Dis; 1994 Aug; 19(2):287-98. PubMed ID: 7986901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database.
    Badley AD; Seaberg EC; Porayko MK; Wiesner RH; Keating MR; Wilhelm MP; Walker RC; Patel R; Marshall WF; DeBernardi M; Zetterman R; Steers JL; Paya CV
    Transplantation; 1997 Jul; 64(1):66-73. PubMed ID: 9233703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s.
    Winston DJ; Gale RP
    Bone Marrow Transplant; 1991 Jul; 8(1):7-11. PubMed ID: 1655140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients.
    Bonaros NE; Kocher A; Dunkler D; Grimm M; Zuckermann A; Ankersmit J; Ehrlich M; Wolner E; Laufer G
    Transplantation; 2004 Mar; 77(6):890-7. PubMed ID: 15077033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.
    De Witte T; Schattenberg A; Van Dijk BA; Galama J; Olthuis H; Van der Meer JW; Kunst VA
    Transplantation; 1990 Dec; 50(6):964-8. PubMed ID: 2175059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.
    Grob JP; Grundy JE; Prentice HG; Griffiths PD; Hoffbrand AV; Hughes MD; Tate T; Wimperis JZ; Brenner MK
    Lancet; 1987 Apr; 1(8536):774-6. PubMed ID: 2882184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.
    Grossi P; Mohacsi P; Szabolcs Z; Potena L
    Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S1-4. PubMed ID: 26900989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.
    Przepiorka D; Ippoliti C; Panina A; Goodrich J; Giralt S; van Besien K; Mehra R; Deisseroth AB; Andersson B; Luna M
    Bone Marrow Transplant; 1994 Apr; 13(4):461-4. PubMed ID: 8019472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cytomegalovirus disease with antiviral drugs.
    Balfour HH
    Rev Infect Dis; 1990; 12 Suppl 7():S849-60. PubMed ID: 2173114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
    Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
    Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.